Impact of Surgical Mask, FFP2 Mask and FFP3 Mask (With and Without Exhalation Valve) on Exercise Tolerance and Blood Gas Parameters of Patients With Known Lung Disease and Long-term Oxygen Therapy
NCT ID: NCT05931016
Last Updated: 2024-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
72 participants
OBSERVATIONAL
2023-06-26
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In particular, the question arises whether patients become hypoxemic or hypercapnic by using a mask. Or whether wearing a mask increases oxygen saturation by its reservoir function.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Face Masks on Pulmonary Function in Patients With COPD
NCT05742880
Effects of Using Mask During the 6-minute Walking Test in Times of COVID-19
NCT04789603
Effect of Home-base Exercise With Conical-PEP Device on Physical Performance and Quality of Life in COPD
NCT02790047
Post COVID-19 REspiratory Mechanisms and the Efficacy of a Breathing Exercise Intervention for DYsregulated Breathing
NCT05732571
Tolerance of Surgical Masks in Chronic Respiratory Diseases
NCT05454631
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with known lung disease and LTOT (long term oxygen therapy)
Patients with i.e. interstitial lung, emphysema, pulmonary hypertension or COPD with the need for LTOT
6-MWT
Measurement of saturation and blood gas parameters under 6-MWT with different masks.
Spiroergometry
Measurement of saturation and blood gas parameters under spiroergometry with different masks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
6-MWT
Measurement of saturation and blood gas parameters under 6-MWT with different masks.
Spiroergometry
Measurement of saturation and blood gas parameters under spiroergometry with different masks.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* LTOT
* informed consent
Exclusion Criteria
* Acute exacerbation of lung disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Regensburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maximilian Malfertheiner
PD Dr. Maximilian Malfertheiner
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinik Donaustauf
Donaustauf, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-3165-101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.